Wedbush Downgrades Cross Country Healthcare to Neutral, Lowers Price Target to $13.25

Cross Country Healthcare, Inc.

Cross Country Healthcare, Inc.

CCRN

0.00

Wedbush analyst Michael Piccolo downgrades Cross Country Healthcare (NASDAQ: CCRN) from Outperform to Neutral and lowers the price target from $15 to $13.25.